Mon panier

Transferrin R

Transferrin R Informations sur la molécule

Nom anglaisTransferrin receptor protein 1Nombre de médicaments commercialisés1
Nombre de médicaments cliniques15Alias de la cibleTFRC,T9,sTfR,Transferrin receptor protein 1,TR,Transferrin Receptor,P90,Transferrin Receptor (P90, CD71),CD71 Antigen,IMD46,CD71,TfR1,Trfr,TfR
Phase de R&D la plus avancéeApproved
Nom anglaisTransferrin receptor protein 1
Alias de la cibleTFRC,T9,sTfR,Transferrin receptor protein 1,TR,Transferrin Receptor,P90,Transferrin Receptor (P90, CD71),CD71 Antigen,IMD46,CD71,TfR1,Trfr,TfR
Nombre de médicaments commercialisés1
Nombre de médicaments cliniques15
Phase de R&D la plus avancéeApproved

Transferrin R Liste de produits

  • Attribut

    Protein (16)Cell (1)

  • Bibliothèque de produits

    En ligne (17)

  • Espèces

    Human (7)Cynomolgus (4)Mouse (4)Rat (2)

  • Étiquette

    His Tag (7)His Tag & Avi Tag (4)Fc Tag (3)Tag Free (2)Fc Tag & Avi Tag (1)

  • Marqueur

    Unconjugated (8)Biotin-labeled (8)- (1)

Transferrin RContexte de la molécule

CD antigen CD71 is also known as Transferrin receptor protein 1, TfR, sTfR, p90, TfR1, Trfr, which belongs to the peptidase M28 family and M28B subfamily. CD71 /TFR contains one PA (protease associated) domain. CD71 / TfR1 is required for iron delivery from transferrin to cells. CD71 is a potential new target in cases of human leukomia & lymphoma. CD71 /TFRC / TfR has been shown to interact with GABARAP and HFE.

Transferrin RAlias de la molécule

CD71,TFRC,TFR,sTfR,TfR1,Trfr,T9,p90

Informations sur les médicaments cliniques

Nom anglaisCode de recherchePhase de R&DEntrepriseIndicationEssai clinique
Human apotransferrin (Sanquin Blood Supply Foundation)Phase 3 ClinicalSanquin Plasma Products Bvbeta-Thalassemia; Iron Metabolism Disorders
Details
Delpacibart braxlosiranAOC1020Phase 3 ClinicalAvidity Biosciences IncFoot-and-Mouth Disease; Muscular Dystrophies; Muscular Dystrophy, Facioscapulohumeral
Details
Delpacibart eteddesiranAOC-1001; AOC 1001Phase 3 ClinicalAvidity Biosciences IncGenetic Diseases, Inborn; Heredodegenerative Disorders, Nervous System; Muscular Atrophy; Muscular Diseases; Muscular Disorders, Atrophic; Muscular Dystrophies; Musculoskeletal Diseases; Myotonia; Myotonic Disorders; Myotonic Dystrophy; Nervous System Diseases; Neurodegenerative Diseases; Neuromuscular Diseases
Details
TrontinemabRO-7126209; RG-6102Phase 3 ClinicalF. Hoffmann-La Roche LtdAlzheimer Disease
Details
CX-2029ABBV-2029; ABBV-CX-2029; CX-2029Phase 2 ClinicalAbbvie Inc, Cytomx Therapeutics IncCarcinoma, Non-Small-Cell Lung; Esophageal Neoplasms; Head and Neck Neoplasms; Lymphoma, Large B-Cell, Diffuse; Solid tumours
Details
Zeleciment rostudirsenDYNE251Phase 2 ClinicalDyne Therapeutics IncMuscular Dystrophy, Duchenne
Details
AOC-1044AOC-1044; AOC 1044Phase 2 ClinicalAvidity Biosciences IncMuscular Dystrophy, Duchenne
Details
JR-446JR-446Phase 2 ClinicalJcr Pharmaceuticals Co Ltd, Medipal Holdings CorpMucopolysaccharidosis III
Details
JR-441JR-441Phase 2 ClinicalJcr Pharmaceuticals Co LtdMucopolysaccharidosis III
Details
Lepunafusp alfaJR-171Phase 2 ClinicalJcr Pharmaceuticals Co LtdMucopolysaccharidosis I
Details
PPMX-T003PPMX-T003Phase 2 ClinicalPerseus Proteomics IncLeukemia; Polycythemia Vera
Details
INA-03INA03Phase 1 ClinicalInatherysLeukemia; Leukemia, Myeloid, Acute; Precursor Cell Lymphoblastic Leukemia-Lymphoma
Details
PRX012-TfRPRX012-TfRPhase 1 ClinicalProthenaAlzheimer Disease
Details
KK-2260KK2260; KK-2260Phase 1 ClinicalKyowa Kirin Co LtdEsophageal Neoplasms; Solid tumours; Squamous Cell Carcinoma of Head and Neck
Details
ABX-1100ABX-1100Phase 1 ClinicalAro Biotherapeutics CoGlycogen Storage Disease Type II
Details

Informations sur les médicaments commercialisés

Nom anglaisCode de recherchePhase de R&DEntreprisePlus ancien nom de marquePays d'approbation le plus ancienIndication la plus ancienneSociété d'approbation la plus ancienneDate d'approbation la plus ancienneIndicationEssai clinique
Pabinafusp alfaJR-141ApprovedJcr Pharmaceuticals Co LtdJapanMucopolysaccharidosis IIJcr Pharmaceuticals Co Ltd2021-03-23Mucopolysaccharidosis II
Details

Avis sur les produits

  • ***a2026-05-29
    0Mettre un like
    Was purchased for use in BLI, both for immobilization onto human fc binding sensors and as analyte with a biotin-labeled TfR-targeting nanobody on streptavidin. Retested for use after 1.5 years storage at -80 and still had full functional activity.
  • S*** 2025-11-18
    0Mettre un like
    Used this material as a captured ligand in routine SPR testing on a Biacore. Material is clean, consistent, and easy to work with, and can be used to generate quality data
  • ZZ2022-10-11
    0Mettre un like
    We needed this product for our antibody research. ACRO managed to get it to us much faster than we expected, which made our research work very accurate. cd71 is a potential new target in human leukemia and lymphoma cases. cd71 /TFRC / TfR has been shown to interact with GABARAP and HFE. I am very pleased with the product and the quick technical support.
Charger plus
  • Informations sur la molécule
  • Liste de produits
  • Informations sur les médicaments commercialisés
  • Avis sur les produits
  • Informations sur les médicaments cliniques